Search / Trial NCT06229054

Dexmedetomidine in Obturator Nerve Block as an Analgesic in Transurethral Surgeries

Launched by CAIRO UNIVERSITY · Jan 19, 2024

Trial Information

Current as of October 08, 2024

Completed

Keywords

Obturator Nerve Block Dexmedetomidine

Description

* After history taking and examination of the labs and airway of the patient , An intravenous catheter will be secured in the dorsum of the hand of non dominant hand and patients will be monitored for heart rate, noninvasive blood pressure, and oxygen saturation. * All patients after aseptic preparation will receive subarachnoid block in lumber 3-4 or 4-5 space in sitting position. * About 3 ml (15mg) of heavy 0.5% bupivacaine will be injected into subarachnoid space. * After the completion of the block, patients will be laid in the supine position and subsequently waited for 5 min for fixa...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Participants will be adults (above 18 years) scheduled to undergo transurethral surgery under regional anesthesia.
  • * ASA1, ASA2
  • Exclusion Criteria:
  • * American Society of Anesthesiologists (ASA) physical class 3,4, severe cardiac comorbidity (impaired contractility with ejection fraction less than 50%, heart block, significant arrhythmias, tight valvular lesions), allergy to any study's drugs

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Cairo, , Egypt

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0